BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nuzziello N, Ciaccia L, Liguori M. Precision Medicine in Neurodegenerative Diseases: Some Promising Tips Coming from the microRNAs' World. Cells 2019;9:E75. [PMID: 31892254 DOI: 10.3390/cells9010075] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Ashraf H, Solla P, Sechi LA. Current Advancement of Immunomodulatory Drugs as Potential Pharmacotherapies for Autoimmunity Based Neurological Diseases. Pharmaceuticals 2022;15:1077. [DOI: 10.3390/ph15091077] [Reference Citation Analysis]
2 Surguchov A. Biomarkers in Parkinson’s Disease. Neurodegenerative Diseases Biomarkers 2022. [DOI: 10.1007/978-1-0716-1712-0_7] [Cited by in Crossref: 7] [Article Influence: 7.0] [Reference Citation Analysis]
3 Shen L, Wang C, Chen L, Wong G. Dysregulation of MicroRNAs and PIWI-Interacting RNAs in a Caenorhabditis elegans Parkinson's Disease Model Overexpressing Human α-Synuclein and Influence of tdp-1. Front Neurosci 2021;15:600462. [PMID: 33762903 DOI: 10.3389/fnins.2021.600462] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
4 Mandolesi G, Rizzo FR, Balletta S, Stampanoni Bassi M, Gilio L, Guadalupi L, Nencini M, Moscatelli A, Ryan CP, Licursi V, Dolcetti E, Musella A, Gentile A, Fresegna D, Bullitta S, Caioli S, Vanni V, Sanna K, Bruno A, Buttari F, Castelli C, Presutti C, De Santa F, Finardi A, Furlan R, Centonze D, De Vito F. The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis. Cells 2021;10:330. [PMID: 33562569 DOI: 10.3390/cells10020330] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
5 Nuzziello N, Liguori M. Pharmacoepigenomics in neurodegenerative diseases. Medical Epigenetics 2021. [DOI: 10.1016/b978-0-12-823928-5.00008-6] [Reference Citation Analysis]
6 Strianese O, Rizzo F, Ciccarelli M, Galasso G, D'Agostino Y, Salvati A, Del Giudice C, Tesorio P, Rusciano MR. Precision and Personalized Medicine: How Genomic Approach Improves the Management of Cardiovascular and Neurodegenerative Disease. Genes (Basel) 2020;11:E747. [PMID: 32640513 DOI: 10.3390/genes11070747] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
7 Shademan B, Nourazarian A, Nikanfar M, Biray Avci C, Hasanpour M, Isazadeh A. Investigation of the miRNA146a and miRNA155 gene expression levels in patients with multiple sclerosis. J Clin Neurosci 2020;78:189-93. [PMID: 32331943 DOI: 10.1016/j.jocn.2020.04.071] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
8 Mazdeh M, Kordestani H, Komaki A, Eftekharian MM, Arsang-Jang S, Branicki W, Taheri M, Ghafouri-Fard S. Assessment of expression profile of microRNAs in multiple sclerosis patients treated with fingolimod. J Mol Neurosci 2020;70:1274-81. [PMID: 32215780 DOI: 10.1007/s12031-020-01537-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]